insights_auto
Why is PFIZ34 down 3.82%?
Dive Deeperchevron_right
PFIZ34:BVMF
Pfizer BDR
R$34.53
arrow_downward
-3.82%(-1.37) 1D
Oct 5, 10:25:05 AM GMT-3 · BRL
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PFIZ34...
Open
R$34.90
High
R$34.90
Low
R$34.45
Mkt. cap
155.83B
Avg. vol.
7.88K
Volume
2.50K
52-wk high
R$37.70
52-wk low
R$30.09
Shares outstanding
5.70B
No. of employees
75K
Open
R$34.90
High
R$34.90
Low
R$34.45
Mkt. cap
155.83B
Avg. vol.
7.88K
Volume
2.50K
52-wk high
R$37.70
52-wk low
R$30.09
Shares outstanding
5.70B
No. of employees
75K
News stories
From web sources and news partners
Investor's Business Daily
·
23 minutes ago
Small Biotech Squares Up To Pfizer, Merck In $7 Billion Market
The Motley Fool
·
50 minutes ago
Eli Lilly vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?
Yahoo Finance
·
2 hours ago
Pfizer’s Turnaround Could Be Bigger Than Investors Think, Set For 20% Upside
AD HOC NEWS
·
5 hours ago
Pfizer presents LITFULO data. 10 analysts rate Pfizer stock Buy
Profile
Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City. Founded in 1849 in New York by German entrepreneurs Charles Pfizer and Charles F. Erhart, Pfizer is one of the oldest pharmaceutical companies in North America.
Pfizer develops and produces medication and vaccines for immunology, oncology, cardiology, endocrinology, and neurology. The company's largest products by sales are Eliquis, Prevnar, Paxlovid, Vyndaqel, Comirnaty, and Ibrance. In 2025, 59% of the company's revenues came from the United States, 5% came from China, and 36% came from other countries.
The company is ranked fifth on the list of largest biomedical companies by revenue. It is ranked the 69th on the Fortune 500 and 73rd on the Forbes Global 2000. Wikipedia
About Pfizer BDR
CEOAlbert Bourla
Employees75K
Founded1849
HeadquartersNew York, New York, United States
SectorPharmaceutical industry
Websitepfizer.com